3 Magnificent Dividend Growth Stocks With Yields Above 5% to Buy Now and Hold at Least a Decade
There are many ways to make money on Wall Street, but some methods are a lot more reliable than others. Whether you're ...
Opinion
Bradford Era19hOpinion
Cancer drug costs nearly $200K
Taxpayers spent $74.5 million to help develop the prostate cancer-fighting drug Xtandi, but its sky-high sticker price is limiting access to patients and siphoning money away from Medicaid, according ...
2 No-Brainer Healthcare Stocks to Buy With $500 Right Now
It's one of the top healthcare stocks in my portfolio. If I didn't already own this biotech stock, I wouldn't hesitate to buy ...
Targeted Oncology17h
FDA Grants Fast Track Designation to 67Cu-SAR-bisPSMA in mCRPC
The FDA has granted fast track status to 67Cu-SAR-bisPSMA for metastatic prostate cancer that is resistant to hormone therapy ...
appliedclinicaltrialsonline17h
ASTRO Trial Shows SC Tremfya Provides Significant Clinical Benefits in Moderately to Severely Active Ulcerative Colitis
Tremfya could become the first IL-23 inhibitor with fully subcutaneous induction and maintenance options in the treatment of ...